Advertisement
UK markets open in 6 hours 12 minutes
  • NIKKEI 225

    37,926.20
    -533.88 (-1.39%)
     
  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     
  • CRUDE OIL

    82.73
    -0.08 (-0.10%)
     
  • GOLD FUTURES

    2,329.50
    -8.90 (-0.38%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • Bitcoin GBP

    51,901.55
    -1,645.04 (-3.07%)
     
  • CMC Crypto 200

    1,394.65
    -29.45 (-2.07%)
     
  • NASDAQ Composite

    15,712.75
    +16.11 (+0.10%)
     
  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     

Is Johnson & Johnson an Underdog in the COVID-19 Vaccine Race?

Is Johnson & Johnson an Underdog in the COVID-19 Vaccine Race?

You won't have a very difficult time identifying ways that Johnson & Johnson (NYSE: JNJ) is a leader. It's the largest healthcare company in the world with a market cap of close to $400 billion. Johnson & Johnson announced in March that it would invest more than $1 billion to develop a COVID-19 vaccine candidate.